Hot Life Science Investor Mandate 3: Pre- and Seed Stage Fund Interested in Medtech & Diagnostics – June 27, 2013

~ Next Phase Admin
A pre-seed and seed stage fund that was established when its state government allocated $7 million in order to promote life science within its borders has managed to grow their initial investment to $20 million. The firm is now seeking new investments in the life sciences space, and typically initially invests around $500,000, but has the ability to invest upwards of $1 million. The firm has an evergreen structure, and thus is always looking for new investment opportunities. With that being said, the firm has no strict timeframe to make an allocation, but would invest in a firm within the next 6-9 months if a compelling opportunity is identified.

This particular firm is interested in the biotech therapeutics and diagnostics space, as well as in medical technologies. Although the firm does invest in therapeutic companies, they are most interested in the diagnostics and medical device space currently. Additionally, they are interested in companies that are developing research tools.

The firm makes seed and seed stage investments, and therefore does not consider firms that have raised a significant amount of venture capital, or more research-oriented projects that are better suited for an NIH grant. Consequently, the firm will consider companies that have a prototype of their medical device, or diagnostics companies that are in the pre-clinical phase of development.

Unknown's avatar

Published by Next Phase Admin

Leave a comment